Brian K Armstrong1, Ivana Romac Coc2, Prateek Agarwal2, Scott Smith2, Samuel Navon2. 1. Cleveland Clinic Abu Dhabi - Eye Institute, Al Maryah Island - Sowwah Square, PO Box 112412, Abu Dhabi, United Arab Emirates. ArmstrB@ClevelandClinicAbuDhabi.ae. 2. Cleveland Clinic Abu Dhabi - Eye Institute, Al Maryah Island - Sowwah Square, PO Box 112412, Abu Dhabi, United Arab Emirates.
Abstract
PURPOSE: Despite the widespread practice of fasting, there are no studies looking at ocular surface inflammation, specifically matrix metalloproteinase 9 (MMP-9) testing, during fasting. In this prospective study, we wanted to evaluate the effect of Ramadan fasting on the level of tear film MMP-9 as well as other standard indicators of dry eye disease. METHODS: Forty healthy patients without history of ocular disease were tested before and toward the end of Ramadan. Each patient was assessed at each timepoint for tear film MMP-9 positivity as measured by a commercially available test (InflammaDry; Quidel Corp., San Diego, CA, USA) which detects MMP-9 levels of more than 40 ng/ml. Ocular surface disease index (OSDI) scores, tear breakup time (TBUT), Schirmer I test (S1T) and corneal fluorescein staining (CFS) were also evaluated at each timepoint. RESULTS: InflammaDry was positive in 10 patients (25%) prior to Ramadan and 21 patients (52.5%) during Ramadan fasting, and this change was statistically significant (p = 0.02). Mean TBUT decreased from 7 s prior to Ramadan to 5.3 s during Ramadan fasting, and this change was statistically significant (p = 0.01). OSDI, CFS and S1T did not show any statistically significant changes (p > 0.05 for all). CONCLUSION: Ramadan fasting has a significant impact on TBUT and ocular surface inflammation detected by Inflamma Dry testing. Patients who suffer from dry eye disease and those who develop symptoms during Ramadan are advised to consult with a physician before or during Ramadan fasting.
PURPOSE: Despite the widespread practice of fasting, there are no studies looking at ocular surface inflammation, specifically matrix metalloproteinase 9 (MMP-9) testing, during fasting. In this prospective study, we wanted to evaluate the effect of Ramadan fasting on the level of tear film MMP-9 as well as other standard indicators of dry eye disease. METHODS: Forty healthy patients without history of ocular disease were tested before and toward the end of Ramadan. Each patient was assessed at each timepoint for tear film MMP-9 positivity as measured by a commercially available test (InflammaDry; Quidel Corp., San Diego, CA, USA) which detects MMP-9 levels of more than 40 ng/ml. Ocular surface disease index (OSDI) scores, tear breakup time (TBUT), Schirmer I test (S1T) and cornealfluorescein staining (CFS) were also evaluated at each timepoint. RESULTS: InflammaDry was positive in 10 patients (25%) prior to Ramadan and 21 patients (52.5%) during Ramadan fasting, and this change was statistically significant (p = 0.02). Mean TBUT decreased from 7 s prior to Ramadan to 5.3 s during Ramadan fasting, and this change was statistically significant (p = 0.01). OSDI, CFS and S1T did not show any statistically significant changes (p > 0.05 for all). CONCLUSION:Ramadan fasting has a significant impact on TBUT and ocular surface inflammation detected by Inflamma Dry testing. Patients who suffer from dry eye disease and those who develop symptoms during Ramadan are advised to consult with a physician before or during Ramadan fasting.
Authors: S Endres; R Ghorbani; V E Kelley; K Georgilis; G Lonnemann; J W van der Meer; J G Cannon; T S Rogers; M S Klempner; P C Weber Journal: N Engl J Med Date: 1989-02-02 Impact factor: 91.245
Authors: Nicole L Lanza; Allison L McClellan; Hatim Batawi; Elizabeth R Felix; Konstantinos D Sarantopoulos; Roy C Levitt; Anat Galor Journal: Ocul Surf Date: 2016-01-22 Impact factor: 5.033
Authors: James H Catterson; Mobina Khericha; Miranda C Dyson; Alec J Vincent; Rebecca Callard; Steven M Haveron; Arjunan Rajasingam; Mumtaz Ahmad; Linda Partridge Journal: Curr Biol Date: 2018-05-17 Impact factor: 10.834
Authors: Rakan Jaser Alsahly; Abdulrahman Abbas Aldawsari; Nawaf Fahad Alzaidy; Faisal Ali Al Jabr; Mamdouh Mohammed Alotaibi; Elsadig Yousef Mohammed Journal: Clin Ophthalmol Date: 2022-02-22